Last updated on February 2018

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan


Brief description of study

The purpose of this post-marketing survey is to obtain real-world information on the safety and effectiveness of evolocumab in Japan.

Detailed Study Description

The objectives of study are to 1) determine the incidence of adverse events and adverse drug reactions among patients receiving evolocumab for up to 2 years, and 2) identify and describe patient characteristics (e.g. demographics, medical history) associated with the safety and effectiveness of evolocumab therapy for the patients with Familial Hypercholesterolemia (Heterozygous or Homozygous) and Hypercholesterolemia in Japan

Clinical Study Identifier: NCT02808403

Contact Investigators or Research Sites near you

Start Over

Amgen Call Center

Research Site
Zentsuji city, Japan
9.32miles
  Connect »

Amgen Call Center

Research Site
Zentsuji City, Japan
9.32miles
  Connect »